FDA-IP Today RSS
Rakesh Amin

Rakesh M. Amin is a Partner at Amin Talati. He practices Food and Drug Administration (FDA), Federal Trade Commission (FTC), U.S. Customs, Drug Enforcement Act (DEA), U.S. Department of Agriculture (USDA) and pharmacy law, and related federal and state regulatory and litigation matters. Amin regularly provides legal counsel regarding food, drug, cosmetic, medical device and biotechnology laws, including various product approval and pre/post marketing requirements, good manufacturing practices, advertising, labeling, health claims, import/detention issues, inspections, regulatory enforcement and complaint matters. He also practices patent, trademark, copyright, trade secret, internet and unfair competition law. His practice includes the prosecution, maintenance and licensing of intellectual property, as well as intellectual property and false advertising litigation.

07/07/2011

FDA Releases Sunscreen Final Rule

FDA’s final rule on sunscreen drug products affects labeling, broad spectrum designations, regulations for water resistance and prohibited claims.
More  |  Comment(s) 

06/07/2011

OTC Liquid Drug Products Guidance

FDA issued a final guidance on ways to improve labeling and dosage delivery devices for OTC liquid drug products in an attempt to minimize the risk of accidental overdose.
More  |  Comment(s) 

05/24/2011

FSMA Means Heightened Standards for Food Safety

Two new regs issued by FDA broaden the agency’s ability to detail foods it believes may believe are adulterated or pose a threat to public health, and require importers to notify FDA if any foods have been refused entry to another country.
More  |  Comment(s) 

05/10/2011

Postponement of the Track One Accelerated Patent Examination Program

Budget woes at the U.S. Patent and Trademark Office mean the accelerated patent examination program has been postponed indefinitely.
More  |  Comment(s) 

04/15/2011

‘First-to-File’: The Sequel

The U.S. Patent and Trademark Office is now offering a fast track for patent applications, which could result in greater efficiency in the patent examination process.
More  |  Comment(s) 

03/23/2011

Patent Reform: A Move to ‘First-to-File’

A pending Senate bill that has White House support would change the U.S. patent system from first-to-invent to first-to-file.
More  |  Comment(s) 

03/07/2011

Ferrari vs. Ford – A Race for ‘F150’

While Ferrari wasn’t using the F150 in commerce, it does appear the Italian automaker will back down from use of the trademarked term used by Ford for its pickup trucks.
More  |  Comment(s) 

02/15/2011

FDA and the Park Doctrine

Corporate officials should be mindful of the criteria used under the Park Doctrine that impose more responsibility—and criminal liability—on them if violations of federal law occur.
More  |  Comment(s) 

01/12/2011

FDA Re-evaluates Portion Sizing

FDA is now allowing a 12-oz. serving size on beverages purchased in containers larger than 20 fluid ounces.
More  |  Comment(s) 

01/04/2011

More FDA Enforcement Ahead

FDA has outlined its plans to increase its enforcement efforts within the dietary supplement industry.
More  |  Comment(s) 

« Previous1234Next »